GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Bellicum Pharmaceuticals
Cellphire Therapeutics, Inc.
Emory University
Terumo BCTbio
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Francisco
University of California, San Francisco